We are live on ! Find out more
VKH

Virtu KCG Holdings Portfolio holdings

AUM $3.6B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
10 Year Est. Return
AUM
$4.06B
AUM Growth
-$150M
Cap. Flow
-$263M
Cap. Flow %
-6.49%
Top 10 Hldgs %
31.74%
Holding
4,242
New
1,199
Increased
1,051
Reduced
1,075
Closed
887

Sector Composition

Rank Sector Weight
1 Financials 8.67%
2 Technology 5.57%
3 Industrials 5.45%
4 Consumer Discretionary 5.35%
5 Healthcare 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRS
3301
DELISTED
Amyris Inc.
AMRS
$8K ﹤0.01%
763
-9,758
-93% -$120K
CVRS
3302
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$8K ﹤0.01%
+11,109
New +$9.35K
BAA
3303
DELISTED
Banro Corporation Common Stock
BAA
$8K ﹤0.01%
4,186
+2,413
+136% +$5.35K
OHGI
3304
DELISTED
One Horizon Group, Inc.
OHGI
$8K ﹤0.01%
+4,695
New +$10.3K
TEAR
3305
DELISTED
TearLab Corporation
TEAR
$8K ﹤0.01%
1,620
-1,631
-50% -$9.27K
GLOWE
3306
DELISTED
GLOWPOINT INC
GLOWE
$8K ﹤0.01%
+29,514
New +$8K
CPHI icon
3307
China Pharma Holdings
CPHI
$45M
$7K ﹤0.01%
+55
New +$5.85K
TMQ
3308
Trilogy Metals
TMQ
$541M
$7K ﹤0.01%
14,517
-9,256
-39% -$4.73K
CDMO
3309
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$7K ﹤0.01%
3,277
-4,684
-59% -$10.9K
AVEO
3310
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$7K ﹤0.01%
+1,354
New +$9.03K
UQM
3311
DELISTED
UQM Technologies, Inc.
UQM
$7K ﹤0.01%
17,340
-7,903
-31% -$4.08K
CYHHZ
3312
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$7K ﹤0.01%
1,465,539
-1,875,069
-56% -$14.6K
FPP
3313
DELISTED
FieldPoint Petroleum Corporation
FPP
$7K ﹤0.01%
10,273
-734
-7% -$455
AXN
3314
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
$7K ﹤0.01%
23,335
-8,984
-28% -$3.72K
FALC
3315
DELISTED
FalconStor Software Inc
FALC
$7K ﹤0.01%
+15,149
New +$10.5K
GCVRZ
3316
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$7K ﹤0.01%
+19,188
New +$6.5K
ANY icon
3317
Sphere 3D
ANY
$18.5M
$6K ﹤0.01%
1
-12
-92% -$88.3K
NUWE icon
3318
Nuwellis
NUWE
$160K
0
JXG
3319
JX Luxventure
JXG
$84.3M
$6K ﹤0.01%
2
-1
-33% -$3.23K
BLPH
3320
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$6K ﹤0.01%
773
-1,386
-64% -$19.3K
WHLRW
3321
DELISTED
Wheeler Real Estate Investment Trust, Inc. Warrants
WHLRW
$6K ﹤0.01%
122,967
+2,269
+2% +$147
KMI.WS
3322
DELISTED
Kinder Morgan Inc
KMI.WS
$6K ﹤0.01%
1,149,263
+1,091,804
+1,900% +$8.41K
OXBRW icon
3323
Oxbridge Re Holdings Ltd Warrant
OXBRW
$5K ﹤0.01%
16,025
+2,638
+20% +$1.09K
PLX icon
3324
Protalix BioTherapeutics
PLX
$191M
$5K ﹤0.01%
1,121
-95
-8% -$424
TRNX
3325
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$5K ﹤0.01%
1
-20
-95% -$173K

Similar funds

Virtu KCG Holdings's Q4 2016 Portfolio in Review

As of Q4 2016, Virtu KCG Holdings held 4,242 positions worth $4.06B, down 3.6% from $4.21B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Virtu KCG Holdings withdrew a net $263M in Q4 2016, closing 887 positions and reducing 1,075 holdings. Its most notable exit was WisdomTree Emerging Markets High Dividend Fund, an estimated $28.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.7% of assets, up from 7% a quarter earlier, followed by Technology and Industrials.

Against the trend, Virtu KCG Holdings opened a new position in Citigroup worth $14.9M.

  • Virtu KCG Holdings's largest Q4 2016 buy was Citigroup: 251,435 shares worth $14.9M.
  • Virtu KCG Holdings added most to Microsoft in Q4 2016, an estimated $10.1M increase.
  • Virtu KCG Holdings's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $86.4M.
  • Virtu KCG Holdings fully exited WisdomTree Emerging Markets High Dividend Fund in Q4 2016, selling an estimated $28.2M.
  • Virtu KCG Holdings's ten largest holdings make up 32% of its $4.06B portfolio in Q4 2016.
  • Virtu KCG Holdings opened 1,199 new positions and closed 887 in Q4 2016.
  • Virtu KCG Holdings's portfolio value fell 3.6% quarter-over-quarter to $4.06B.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.